Tomarce, Reyna Mae .
HRN: 11-92-82 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/18/2022
06/25/2022
IV
100 Mg
Q24
PCAP D
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes